Viva Biotech’s 2023 Overseas Appreciation Receptions Prove to be a Great Success Again
We’re thrilled to share the success of our recent “Viva Biotech’s 2023 Overseas Appreciation Receptions” in Boston and San Francisco, where we are able to share and exemplify some of our most recent advancements in innovative Drug Discovery services. Nearly 200 biopharma leaders, innovators, and partners joined us, making it a melting pot of ideas and discussions. Thanks to everyone who took time to attend and to contribute to the insightful discussions.
Learn more about this event
Similar news articles
May 15, 2023
SYNthesis med chem joins Lean Life Science’s Oncology Development Programme (ODP2)
SYNthesis med chem has joined Lean Life Science’s Oncology Development Programme (ODP2), a…
Read more
July 1, 2023
SYNthesis med chem, Viva Biotech providing innovation and support to Targeted Protein Degradation (TPD) Drug Discovery projects
At SYNthesis med chem, we are working alongside colleagues at Viva Biotech to provide access to all…
Read more
September 21, 2023
SYNthesis med chem, Cytopia and Ojjaara
In the late 2000’s, a small Australian biotech – Cytopia – discovered a molecule capable of…
Read more